About Glia-derived nexin
Glia-derived nexin (SERPINE2) is a protein
from Homo sapiens identified by UniProt accession
P07093, 398 residues long.
MolForge cross-references it against 0 known binders and
188 disease associations.
Target properties
| Protein name | Glia-derived nexin |
| UniProt accession | P07093 |
| Gene | SERPINE2 |
| Organism | Homo sapiens |
| Length | 398 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (188)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.50
- mean platelet volume · score 0.47
- body height · score 0.45
- platelet-derived growth factor BB measurement · score 0.44
- interleukin 10 measurement · score 0.37
- inflammatory biomarker measurement · score 0.33
- CCL13 measurement · score 0.31
- BMI-adjusted waist circumference · score 0.29
- vascular endothelial growth factor measurement · score 0.28
- interleukin 12 measurement · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P07093-F1 | alphafold | PREDICTED | 88.36 | — |
Amino-acid sequence (398 residues)
MNWHLPLFLL ASVTLPSICS HFNPLSLEEL GSNTGIQVFN QIVKSRPHDN IVISPHGIAS VLGMLQLGAD GRTKKQLAMV MRYGVNGVGK ILKKINKAIV SKKNKDIVTV ANAVFVKNAS EIEVPFVTRN KDVFQCEVRN VNFEDPASAC DSINAWVKNE TRDMIDNLLS PDLIDGVLTR LVLVNAVYFK GLWKSRFQPE NTKKRTFVAA DGKSYQVPML AQLSVFRCGS TSAPNDLWYN FIELPYHGES ISMLIALPTE SSTPLSAIIP HISTKTIDSW MSIMVPKRVQ VILPKFTAVA QTDLKEPLKV LGITDMFDSS KANFAKITTG SENLHVSHIL QKAKIEVSED GTKASAATTA ILIARSSPPW FIVDRPFLFF IRHNPTGAVL FMGQINKP
Explore Glia-derived nexin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets